Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer
2017 · Biomedicine & Pharmacotherapy · 87 citations
https://doi.org/10.1016/j.biopha.2017.09.019
W
Weibo Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
1.7K
Citations
24
h-index
42
i10-index
Weibo Xu is an academic researcher from Liaocheng University. The author has contributed to research in topics: Thyroid Cancer Diagnosis and Treatment & Ferroptosis and cancer prognosis & RNA modifications and cancer. The author has an h-index of 24, co-authored 68 publications.
Papers by this author
worksA 5′-tRNA halve, tiRNA-Gly promotes cell proliferation and migration via binding to RBM17 and inducing alternative splicing in papillary thyroid cancer
2021 · Journal of Experimental & Clinical Cancer Research · 66 citations
https://doi.org/10.1186/s13046-021-02024-3
A spatially resolved transcriptome landscape during thyroid cancer progression
2025 · Cell Reports Medicine · 19 citations
https://doi.org/10.1016/j.xcrm.2025.102043
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer
2021 · Frontiers in Oncology · 7 citations
https://doi.org/10.3389/fonc.2021.641851
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer
2024 · Advanced Science · 7 citations
https://doi.org/10.1002/advs.202413514
Supplementary data for the manuscript: LINC00886 negatively regulates malignancy in anaplastic thyroid cancer
2023 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.21547851
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat